| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/13/2005 | US20050010052 P2X7 receptor (a ligand-gated ion channel) antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases; osteoarthritis |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050009797 Androstane derivative having substituent in 7- abd 17--positions |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050008691 Bicalutamide compositions |
| 01/13/2005 | US20050008655 Useful as barrier applied to skin; chemical and radiation resistance; skin disorders; autoimmune diseases; antitumor agents; topical applying |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | CA2530866A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | CA2530119A1 Buffered compositions for dialysis |
| 01/12/2005 | EP1496059A1 Fused bicyclic pyrimidine derivatives |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents |
| 01/12/2005 | EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495018A1 Tricyclic thrombin receptor antagonists |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1495000A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494730A1 Composition for hard tissue augmentation |
| 01/12/2005 | EP1494705A1 A composition and method for killing of tumours |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/12/2005 | EP1494698A2 Compositions and methods for treating and preventing necrosis |
| 01/12/2005 | EP1494683A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| 01/12/2005 | EP1494674A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494659A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt |
| 01/12/2005 | EP1313494B1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | EP1299373B1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 01/12/2005 | EP1230209B1 Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 01/12/2005 | EP1077711B1 Treatment of papilloma virus infection using a mycobacterium |
| 01/12/2005 | EP1063987A4 Dietary control of arachidonic acid metabolism |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564691A Interval drug release system of convulsion relieving agent |
| 01/12/2005 | CN1564689A Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1564682A Compositions for potentiating glutatthione |
| 01/12/2005 | CN1562315A 'Niaoduqing' granule taken after being mixed with boiling water for cutting uraemia |
| 01/12/2005 | CN1562310A Soft capsule preparation of Tibet medicine 'unique taste' |
| 01/12/2005 | CN1562303A Soft capsules of guifu dihuang and preparation method |
| 01/12/2005 | CN1562286A Medication for curing nephritis and producing method |
| 01/12/2005 | CN1562284A Suppository for detoxicating and promoting blood circulation |
| 01/12/2005 | CN1562274A Preparation of pure Chinese traditional medicine for curing acute nephritis and chronic nephritis |
| 01/12/2005 | CN1562225A Medication for curing hematuria caused by multiform kidney disease and it prepn. process |
| 01/12/2005 | CN1562222A Medicination for curing kidney disease and preparation method |
| 01/12/2005 | CN1562195A Mediciation for curing chronic kidney function failure and its prepn. method |
| 01/12/2005 | CN1562189A Chinese materia medica preparation for treating prostatitis and preparation technique |
| 01/12/2005 | CN1562179A Chinese materia medica preparation for treating hyperplasia of prostate and preparation method |
| 01/12/2005 | CN1562135A Chinese medicine for treating kidney disease and its preparing method |
| 01/12/2005 | CN1562116A Chinese medicine preparation with invigorating kidney function |
| 01/12/2005 | CN1562114A Medicine for treating chronic prostatitis and its preparing method |
| 01/12/2005 | CN1562113A Medicine for treating chronic pelvic inflammation and its preparing method |
| 01/12/2005 | CN1562104A Chinese patented medicine for treating nephritis |
| 01/12/2005 | CN1562092A Effective part extract of Chinese medicine drynaria rhizome and its extracting method |
| 01/12/2005 | CN1562069A Use of C-ski gene and its polypeptide in preparing medicine for improving tissue repairing and reducing scar formation |
| 01/12/2005 | CN1562043A Epristeride dripping pills and its preparing method |
| 01/12/2005 | CN1562028A Flunarizine hydrochoride injection and preparing method |
| 01/12/2005 | CN1561988A Method for preparing taxol micro ball anti-cancer medicine |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183951C Medicine for treating non-gonococcal vaginitis and preparation method |
| 01/12/2005 | CN1183945C Medicine for treating urinary culculus |
| 01/12/2005 | CN1183933C Medicine for treating incomplete kidney function and its prepn |
| 01/12/2005 | CN1183931C Medicine for treating kidney disease |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841575 Fewer side and/or analgesic effects |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841568 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 01/11/2005 | US6841545 Heat resistance; anticancer drug |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/06/2005 | WO2005000825A1 Thiazolimine compound and oxazolimine compound |
| 01/06/2005 | WO2005000356A1 Remedy for urinary tract diseases |
| 01/06/2005 | WO2005000354A1 Preventive/remedy for urinary disturbance |
| 01/06/2005 | WO2005000311A1 Substituted diketopiperazines for the treatment of benign prostatic hyperplasia |
| 01/06/2005 | WO2005000293A1 Therapeutic agent for overactive bladder accompanying cerebrovascular disorder |
| 01/06/2005 | WO2004082574A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 01/06/2005 | WO2004073588A3 Diagnostics and therapeutics for diseases associated with g protein coupled receptor r35 (r35) |
| 01/06/2005 | WO2004073586A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 01/06/2005 | WO2004071378A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004223 Novel 3,3-diphenylpropylamines useful in therapy |